S-1 (Teysuno®): A Review of Its Use in Advanced Gastric Cancer in Non-Asian Populations
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
S-1 (Teysuno®): A Review of Its Use in Advanced Gastric Cancer in Non-Asian Populations
Authors
Keywords
Overall Survival, Advanced Gastric Cancer, Tegafur, Cyanuric Acid, Gimeracil
Journal
DRUGS
Volume 73, Issue 8, Pages 845-855
Publisher
Springer Nature
Online
2013-05-29
DOI
10.1007/s40265-013-0062-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- REG Iα is a biomarker for predicting response to chemotherapy with S-1 plus cisplatin in patients with unresectable stage IV gastric cancer
- (2013) A Sekikawa et al. BRITISH JOURNAL OF CANCER
- Phosphorylated AMP-activated protein kinase expression associated with prognosis for patients with gastric cancer treated with cisplatin-based adjuvant chemotherapy
- (2012) Byung Woog Kang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- S-1 as a core anticancer fluoropyrimidine agent
- (2012) Koh Miura et al. Expert Opinion on Drug Delivery
- S-1 for the treatment of gastrointestinal cancer
- (2012) Taroh Satoh et al. EXPERT OPINION ON PHARMACOTHERAPY
- CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients
- (2011) S R Park et al. BRITISH JOURNAL OF CANCER
- Japanese gastric cancer treatment guidelines 2010 (ver. 3)
- (2011) Gastric Cancer
- Phase I Study of Two Schedules of Oral S-1 in Combination with Fixed Doses of Oxaliplatin and Bevacizumab in Patients with Advanced Solid Tumors
- (2011) Ki Y. Chung et al. ONCOLOGY
- Latest developments and emerging treatment options in the management of stomach cancer
- (2011) Thierry Delaunoit Cancer Management and Research
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) A. Okines et al. ANNALS OF ONCOLOGY
- Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial
- (2010) Jaffer A. Ajani et al. JOURNAL OF CLINICAL ONCOLOGY
- Biomarker analysis in patients with advanced gastric cancer treated with S-1 plus cisplatin chemotherapy: orotate phosphoribosyltransferase expression is associated with treatment outcomes
- (2010) In Sil Choi et al. MEDICAL ONCOLOGY
- A predictive factor for the response to S-1 plus cisplatin in gastric cancer
- (2010) Ikuko Miyazaki WORLD JOURNAL OF GASTROENTEROLOGY
- Phase I/II studies of combination chemotherapy with S-1 and platinum in patients with previously untreated metastatic or recurrent gastric cancer
- (2009) Yoon-Koo Kang Gastric Cancer
- Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancer
- (2009) Wasaburo Koizumi et al. INTERNATIONAL JOURNAL OF CANCER
- Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study
- (2009) Narikazu Boku et al. LANCET ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started